French Researchers Test Implantable Pump


By: dhtest

A study from France has concluded that implantable insulin pumps have proven to be reasonably safe and effective on a large scale, although time-limited, basis. The study was conducted by researchers from the EVADIAC Group in France.

As of January 1992, 7 centers in France have reported 171 pump implantations in 162 patients with type I diabetes representing 145 patients-years of experience. There has been no report of death, pump overflow, or severe infection, and only 2 patients have chosen to return to conventional insulin injections.

Rates for the need to reoperate because of the pump have been 15.3% for catheter malfunction, and 8.3% for the pump site, including 3 pump failures, and 6 pump-pocket erosions/infections. Severe hypoglycemia and ketoacidosis rates were 6.2 and 5.5% patient-years respectively. Overall diabetes control and glycemic fluctuations slightly improved when compared to preimplantation.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.